MOACM
ACOR

Mutual of America Capital Management’s Acorda Therapeutics ACOR Stock Holding History

Mutual of America Capital Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18
Closed -$2K – 1706
2020
Q1 		$2K Buy
18
+3
+20% +$591 ﹤0.01% 1686
2019
Q4 		$4K Hold
15
– – ﹤0.01% 1689
2019
Q3 		$5K Buy
15
+3
+25% +$1.63K ﹤0.01% 1684
2019
Q2 		$11K Buy
12
+3
+33% +$3.69K ﹤0.01% 1646
2019
Q1 		$15K Buy
9
+1
+13% +$1.8K ﹤0.01% 1586
2018
Q4 		$15K Buy
8
+2
+33% +$4.35K ﹤0.01% 1544
2018
Q3 		$15K Buy
6
+5
+500% +$15.5K ﹤0.01% 1552
2018
Q2 		$5K Buy
+1
New +$3.06K ﹤0.01% 1418
2017
Q2 		– Sell
-208
Closed -$525K – 1222
2017
Q1 		$525K Sell
208
-335
-62% -$964K 0.01% 1114
2016
Q4 		$1.22M Sell
543
-2
-0.4% -$4.75K 0.02% 974
2016
Q3 		$1.37M Sell
545
-9
-2% -$26.9K 0.03% 914
2016
Q2 		$1.7M Hold
554
– – 0.04% 776
2016
Q1 		$1.76M Sell
554
-3
-0.5% -$12.5K 0.04% 741
2015
Q4 		$2.86M Buy
557
+3
+0.5% +$13.1K 0.06% 466
2015
Q3 		$1.76M Sell
554
-3
-0.5% -$11.6K 0.04% 721
2015
Q2 		$2.23M Buy
557
+3
+0.5% +$11.6K 0.05% 658
2015
Q1 		$2.21M Buy
554
+120
+28% +$550K 0.05% 667
2014
Q4 		$2.13M Buy
434
+15
+4% +$64.4K 0.05% 676
2014
Q3 		$1.7M Hold
419
– – 0.04% 754
2014
Q2 		$1.69M Sell
419
-25
-6% -$102K 0.04% 779
2014
Q1 		$2.02M Hold
444
– – 0.05% 667
2013
Q4 		$1.56M Buy
444
+141
+47% +$550K 0.04% 797
2013
Q3 		$1.25M Buy
303
+7
+2% +$30.2K 0.03% 846
2013
Q2 		$1.17M Buy
+296
New +$1.22M 0.03% 823

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mutual of America Capital Management's ACOR Position: Q2 2020 in Review

Mutual of America Capital Management sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 18 shares — an estimated $2K sold.

Mutual of America Capital Management first reported a position in ACOR in Q2 2013 and held it in 24 quarters. The position peaked at $2.86M in Q4 2015. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Mutual of America Capital Management reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Mutual of America Capital Management sold 18 Acorda Therapeutics shares in Q2 2020, an estimated $2K.
  • Mutual of America Capital Management first reported a position in Acorda Therapeutics in Q2 2013 and held it in 24 quarters.
  • Mutual of America Capital Management's Acorda Therapeutics position peaked at $2.86M in Q4 2015.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Mutual of America Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.